Deciphering the Genetic Architecture of Autoimmune Diseases | MicrobiomeTrials← Back to trialsNCT06948110
Deciphering the Genetic Architecture of Autoimmune Diseases
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-11-01Est. Completion: 2030-04-22
Enrollment target: 300 participants Locations- National Human Genome Research Institute (NHGRI), Bethesda, Maryland, United States
- Amazon Rainforest, Lima, Peru
Other microbiome trials you might be interested in
B-cell Mediated Autoimmune Disorders
The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-c…
La Jolla, United StatesEst. completion Dec 1, 2026
Chronic Inflammatory Demyelinating PolyneuropathyCIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy
The main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study…
Birmingham, United StatesEst. completion Oct 7, 2027
Type 1 Diabetes
This is a prospective, non-randomized, observational cohort study conducted in adult patients with type 1 diabetes.Parti…
Athens, GreeceEst. completion Sep 1, 2022